Skip to main content
Erschienen in: Drug Safety 8/2009

01.08.2009 | Original Research Article

Application of the Bow-Tie Model in Medication Safety Risk Analysis

Consecutive Experience in Two Hospitals in the Netherlands

verfasst von: Drs Peter C. Wierenga, Loraine Lie-A-Huen, Sophia E. de Rooij, Niek S. Klazinga, Henk-Jan Guchelaar, Susanne M. Smorenburg

Erschienen in: Drug Safety | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Background: To improve medication safety effectively, one should systematically analyse and assess the risks for medication errors and determine the possible causes. So far, no risk-analysis instrument exists in healthcare that can be used to analyse and visualize risks, causes and consequences of potential adverse events in a prospective manner. In high-risk industries such as petrochemistry and aviation, the Bow-Tie model is frequently used. This model combines causes, errors, preventive and recovery measures, and consequences in one model and gives insight into the magnitude and causes of existing safety risks. The aim of our project was to study the usefulness of the Bow-Tie model in the hospital setting for prospective analysis of risks in the medication process in order to develop a practicable method.
Methods: The model was first adapted to the clinical setting. Thereafter, the risk-analysis model was applied in a large tertiary teaching hospital in multi-disciplinary sessions. The sessions and risk-analysis method were evaluated on the following aspects: applicability, comprehensibility, creation of awareness in and motivation of participants, and the capability of the ‘system approach’ (the approach taken by the Bow-Tie model, which focuses on the conditions under which individuals work and tries to build defences to avert errors or mitigate their effects, in contrast to a ‘person approach’, which focuses on errors of individuals, blaming them for forgetfulness, inattention etc.). Based on this evaluation, the risk analysis method was adjusted and consecutively applied in a general teaching hospital. After evaluation of the sessions in the second hospital a recommended method for risk analysis with the Bow-Tie model was defined.
Results: The risk-analysis method with the Bow-Tie model in the first hospital gave insight into many medication safety-related risks. However, the method was insufficient on comprehensibility and on the creation of awareness and motivation owing to a great number of determined risks which made thorough analysis, drawing of Bow-Ties and prioritizing difficult. The adjusted method in the second hospital focused more on the in-depth analysis of a small number of important safety issues of a department with specific attention for underlying causes. This approach was considered better in applicability, comprehensibility and the creation of awareness. Furthermore, by analyzing underlying causes, more attention could be paid to latent conditions (which can translate into error-provoking conditions) within the system.
Conclusion: We found the Bow-Tie to be an appropriate model for prospective risk analysis of medication safety in a hospital. By applying the model in two hospitals consecutively we developed a feasible method for risk-analysis sessions. Key factors of this recommended method are a focus on the prioritized selection of safety issues and specific attention to latent conditions within the system by analysing these safety issues in depth to the root causes with the help of the Bow-Tie model.
Literatur
1.
Zurück zum Zitat Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991; 324(6): 370–6PubMedCrossRef Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991; 324(6): 370–6PubMedCrossRef
2.
Zurück zum Zitat Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324(6): 377–84PubMedCrossRef Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324(6): 377–84PubMedCrossRef
3.
Zurück zum Zitat Wilson RM, Runciman WB, Gibberd RW, et al. The Quality in Australian Health Care Study. Med J Aust 1995; 163(9): 458–71PubMed Wilson RM, Runciman WB, Gibberd RW, et al. The Quality in Australian Health Care Study. Med J Aust 1995; 163(9): 458–71PubMed
4.
Zurück zum Zitat Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170(11): 1678–86PubMedCrossRef Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170(11): 1678–86PubMedCrossRef
5.
Zurück zum Zitat Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001; 322(7285): 517–9PubMedCrossRef Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001; 322(7285): 517–9PubMedCrossRef
6.
Zurück zum Zitat Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274(1): 29–34PubMedCrossRef Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274(1): 29–34PubMedCrossRef
7.
Zurück zum Zitat Hardmeier B, Braunschweig S, Cavallaro M, et al. Adverse drug events caused by medication errors in medical in-patients. Swiss Med Wkly 2004; 134(45–46): 664–70PubMed Hardmeier B, Braunschweig S, Cavallaro M, et al. Adverse drug events caused by medication errors in medical in-patients. Swiss Med Wkly 2004; 134(45–46): 664–70PubMed
8.
Zurück zum Zitat Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med 2004 May 18; 140(10): 795–801PubMed Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med 2004 May 18; 140(10): 795–801PubMed
9.
Zurück zum Zitat Van de Graaf G, Milne P. HSE cases-some lessons learned. Exploration and production newsletter. The Hague: Shell International, 1996 Van de Graaf G, Milne P. HSE cases-some lessons learned. Exploration and production newsletter. The Hague: Shell International, 1996
11.
Zurück zum Zitat Hudson PT, Guchelaar HJ. Risk assessment in clinical pharmacy. Pharm World Sci 2003; 25(3): 98–103PubMedCrossRef Hudson PT, Guchelaar HJ. Risk assessment in clinical pharmacy. Pharm World Sci 2003; 25(3): 98–103PubMedCrossRef
12.
Zurück zum Zitat Guchelaar HJ, Colen HB, Kalmeijer MD, et al. Medication errors: hospital pharmacist perspective. Drugs 2005; 65(13): 1735–46PubMedCrossRef Guchelaar HJ, Colen HB, Kalmeijer MD, et al. Medication errors: hospital pharmacist perspective. Drugs 2005; 65(13): 1735–46PubMedCrossRef
13.
Zurück zum Zitat Reason JT. Managing the risks of organisational accidents. Aldershot: Ashgate, 2006 Reason JT. Managing the risks of organisational accidents. Aldershot: Ashgate, 2006
15.
Zurück zum Zitat Sweitzer SC, Silver MP. Learning from unexpected events: a root cause analysis training program. J Healthc Qual 2005; 27(5): 11–9PubMedCrossRef Sweitzer SC, Silver MP. Learning from unexpected events: a root cause analysis training program. J Healthc Qual 2005; 27(5): 11–9PubMedCrossRef
16.
Zurück zum Zitat Friedman AL, Geoghegan SR, Sowers NM, et al. Medication errors in the outpatient setting: classification and root cause analysis. Arch Surg 2007; 142(3): 278–83PubMedCrossRef Friedman AL, Geoghegan SR, Sowers NM, et al. Medication errors in the outpatient setting: classification and root cause analysis. Arch Surg 2007; 142(3): 278–83PubMedCrossRef
17.
Zurück zum Zitat Braithwaite J, Westbrook MT, Mallock NA, et al. Experiences of health professionals who conducted root cause analyses after undergoing a safety improvement programme. Qual Saf Health Care 2006; 15(6): 393–9PubMedCrossRef Braithwaite J, Westbrook MT, Mallock NA, et al. Experiences of health professionals who conducted root cause analyses after undergoing a safety improvement programme. Qual Saf Health Care 2006; 15(6): 393–9PubMedCrossRef
18.
Zurück zum Zitat Battles JB, Shea CE. A system of analyzing medical errors to improve GME curricula and programs. Acad Med 2001; 76(2): 125–33PubMedCrossRef Battles JB, Shea CE. A system of analyzing medical errors to improve GME curricula and programs. Acad Med 2001; 76(2): 125–33PubMedCrossRef
19.
Zurück zum Zitat Usin MF, Ramesh P, Lopez CG. Implementation of an event reporting system in a transfusion medicine unit: a local experience. Malays J Pathol 2004; 26(1): 43–8PubMed Usin MF, Ramesh P, Lopez CG. Implementation of an event reporting system in a transfusion medicine unit: a local experience. Malays J Pathol 2004; 26(1): 43–8PubMed
20.
Zurück zum Zitat Kozakiewicz JM, Benis LJ, Fisher SM, et al. Safe chemotherapy administration: using failure mode and effects analysis in computerized prescriber order entry. Am J Health Syst Pharm 2005; 62(17): 1813–6PubMedCrossRef Kozakiewicz JM, Benis LJ, Fisher SM, et al. Safe chemotherapy administration: using failure mode and effects analysis in computerized prescriber order entry. Am J Health Syst Pharm 2005; 62(17): 1813–6PubMedCrossRef
21.
Zurück zum Zitat Adachi W, Lodolce AE. Use of failure mode and effects analysis in improving the safety of i.v. drug administration. Am J Health Syst Pharm 2005; 62(9): 917–20PubMed Adachi W, Lodolce AE. Use of failure mode and effects analysis in improving the safety of i.v. drug administration. Am J Health Syst Pharm 2005; 62(9): 917–20PubMed
22.
Zurück zum Zitat Coles G, Fuller B, Nordquist K, et al. Using failure mode effects and criticality analysis for high-risk processes at three community hospitals. Jt Comm J Qual Patient Saf 2005; 31(3): 132–40PubMed Coles G, Fuller B, Nordquist K, et al. Using failure mode effects and criticality analysis for high-risk processes at three community hospitals. Jt Comm J Qual Patient Saf 2005; 31(3): 132–40PubMed
23.
Zurück zum Zitat Duwe B, Fuchs BD, Hansen-Flaschen J. Failure mode and effects analysis application to critical care medicine. Crit Care Clin 2005; 21(1): 21–30, viiPubMedCrossRef Duwe B, Fuchs BD, Hansen-Flaschen J. Failure mode and effects analysis application to critical care medicine. Crit Care Clin 2005; 21(1): 21–30, viiPubMedCrossRef
24.
Zurück zum Zitat van Tilburg CM, Leistikow IP, Rademaker CM, et al. Health care failure mode and effect analysis: a useful proactive risk analysis in a pediatric oncology ward. Qual Saf Health Care 2006; 15(1): 58–63PubMedCrossRef van Tilburg CM, Leistikow IP, Rademaker CM, et al. Health care failure mode and effect analysis: a useful proactive risk analysis in a pediatric oncology ward. Qual Saf Health Care 2006; 15(1): 58–63PubMedCrossRef
25.
Zurück zum Zitat Day S, Dalto J, Fox J, et al. Failure mode and effects analysis as a performance improvement tool in trauma. J Trauma Nurs 2006; 13(3): 111–7PubMed Day S, Dalto J, Fox J, et al. Failure mode and effects analysis as a performance improvement tool in trauma. J Trauma Nurs 2006; 13(3): 111–7PubMed
26.
Zurück zum Zitat Wetterneck TB, Skibinski KA, Roberts TL, et al. Using failure mode and effects analysis to plan implementation of smart i.v. pump technology. Am J Health Syst Pharm 2006; 63(16): 1528–38PubMedCrossRef Wetterneck TB, Skibinski KA, Roberts TL, et al. Using failure mode and effects analysis to plan implementation of smart i.v. pump technology. Am J Health Syst Pharm 2006; 63(16): 1528–38PubMedCrossRef
27.
Zurück zum Zitat Robinson DL, Heigham M, Clark J. Using failure mode and effects analysis for safe administration of chemotherapy to hospitalized children with cancer. Jt Comm J Qual Patient Saf 2006; 32(3): 161–6PubMed Robinson DL, Heigham M, Clark J. Using failure mode and effects analysis for safe administration of chemotherapy to hospitalized children with cancer. Jt Comm J Qual Patient Saf 2006; 32(3): 161–6PubMed
28.
Zurück zum Zitat Bonnabry P, Cingria L, Sadeghipour F, et al. Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions. Qual Saf Health Care 2005; 14(2): 93–8PubMedCrossRef Bonnabry P, Cingria L, Sadeghipour F, et al. Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions. Qual Saf Health Care 2005; 14(2): 93–8PubMedCrossRef
Metadaten
Titel
Application of the Bow-Tie Model in Medication Safety Risk Analysis
Consecutive Experience in Two Hospitals in the Netherlands
verfasst von
Drs Peter C. Wierenga
Loraine Lie-A-Huen
Sophia E. de Rooij
Niek S. Klazinga
Henk-Jan Guchelaar
Susanne M. Smorenburg
Publikationsdatum
01.08.2009
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 8/2009
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200932080-00005

Weitere Artikel der Ausgabe 8/2009

Drug Safety 8/2009 Zur Ausgabe